This is the classic coupon strategy to maximize revenue - if you set the price very high but offer discounts to those who can't afford it, you can get more revenue than if you pick a single price that would be less than what some buyers were willing to pay and more than others were willing to pay.
In the first example of the article, an older woman (Susan Mannes) had to take on a second job to afford a drug that Valeant increased the price on in order to keep her husband from dying. I don't know what the upper limit is on how much Susan and Bruce Mannes will pay for this drug, but I suspect it is limited only by their current assets. In other words, Valeant could feasibly take everything they own.
I don't see a way out of this without regulation, and I don't see that happening when the pharmaceutical industry has been so effective at influencing federal laws.